Allan Kuma

Donate

Knowledge + Media
- Latest News
  
  New international grants to fuel next-generation malaria vaccines
  
  Empowering regional leaders thorough the Australia Awards Fellowships
  
  Parents and teens prefer conversations over porn-blocking technology
  
  Exploring drug use in older adults: APSAD 2024
  
  VIEW ALL
  
  More from Burnet
  
  Research Reports + Policy Briefs
  
  IMPACT Magazine
  
  Events
  
  Research Articles
  
  How Science Matters Podcast
  
  Study at Burnet
Research
- Research
  
  Core Programs
  
  Flagship Initiatives
  
  Technical Focuses
  
  Communities
  
  Health Themes
  
  Working Groups
  
  Projects
  
  Publications
  
  Reports + Policy Briefs
  
  Latest Research Articles
  
  Exploring the Feasibility and Acceptability of Technological Interventions to Pr...
  
  Stellabody®: A novel hexamer-promoting mutation for improved IgG potency
  
  Dynamic nucleolar targeting of dengue virus polymerase NS5 in response to extrac...
  
  20-year trends in Australian methamphetamine-related deaths, 2001-2020.
  
  VIEW ALL RESEARCH ARTICLES
  
  Flagship Initiatives
Technologies
- Technologies
  
  Commercialisation at Burnet
  
  Burnext accelerator program
  
  News + Updates
  
  Vaccines
  
  Diagnostics
  
  Therapeutics
  
  Antibody Platforms
  
  Vaccines
  
  Diagnostics
  
  Therapeutics
  
  Antibody Platforms
Global Impact
- Global Impact
  
  Advancing Health Equity
  
  Partnerships, Community Engagement, Co-Design
  
  Where We Work
  
  Impact Stories
  
  Countries of Focus
  
  Australia
  
  Papua New Guinea
  
  Myanmar
People of Burnet
- People of Burnet
  
  Staff + Students
  
  Board Members
  
  Executive Committee
  
  Leadership
  
  Working Groups
  
  Patrons + Ambassadors
  
  Burnet Partners
  
  People of Burnet
  
  Leadership
  
  Burnet Partners
  
  Board Members
Support Us
- Support Us
  
  Appeals
  
  Supporter Stories
  
  Thanks to you newsletter
  
  Donate Now
  
  How to Help
  
  Current Appeal
  
  Monthly Giving
  
  Trusts + Foundations
  
  Corporate Supporters
  
  Giving in Wills + Bequests
  
  Supporter Stories
The Institute
- The Institute
  
  About Us
  
  History
  
  Careers
  
  Study at Burnet
  
  Internal Initiatives
  
  Annual + Financial Reports
  
  Contact Us
  
  Policies
  
  Accessibility
  
  About Us
  
  Careers
  
  History
  
  Annual + Financial Reports

Home
People of Burnet
People
Allan Kuma

Allan Kuma

Project Lead Counsellor

Profile
Working Groups
Programs
Projects

Information
Working Groups
Core Programs
Projects

Current Projects

Papua New Guinea and the Republic of Indonesia for the Micro Elimination of TB (PRIME-TB) PROJECT

Subscribe to Burnet

Knowledge + Media

News + Updates
IMPACT Magazine
Events
Podcasts
Research Articles
Research Reports + Policy Briefs

Research

Core Programs
Flagship Initiatives
Technical Focuses
Communities
Health Themes
Working Groups
Projects
Publications
Reports + Policy Briefs

Technologies

Commercialisation at Burnet
Burnext accelerator program
News + Updates
Vaccines
Diagnostics
Therapeutics
Antibody Platforms

Global Impact

Advancing Health Equity
Partnerships, Community Engagement, Co-Design
Where We Work
Impact Stories

Support Us

Appeals
Monthly Giving
Giving in Wills + Bequests
Trusts + Foundations
Corporate Supporters
Supporter Stories
Thanks to you newsletter

The Institute

About Us
People of Burnet
History
Careers
Study at Burnet
Internal Initiatives
Annual + Financial Reports
Contact Us
Policies

Privacy policy
Contact us
Copyright and disclaimer
Accessibility

Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present. We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.

Follow us:

Burnet Institute is a member of the Australian Council for International Development (ACFID)

Disclosure of interest

Burnet Institute is an independent medical research institute and like other medical research institutes in Victoria, receives competitive funding support for its research programs from many sources including the National Health and Medical Research Council, Medical Research Future Fund, Operational Infrastructure Support Scheme of the State Government of Victoria, Victorian Medical Research Accelerator Fund, as well as the Department of Foreign Affairs and Trade, philanthropic support from the Australian community, and various national and international Trusts and Foundations.

Burnet Institute owns registered trademarks to its name and pending trademarks to the ‘reach for the many’ logo and word marks found on our website.

ABN 49 007 349 984 © 2024 Burnet Institute. All Rights Reserved.